เด เด-เดฌเตเดเตเดเดฟเดจเตเดเตเดเตเดฑเดฟเดเตเดเต
Each article contains detailed and authoritative information about the adverse effects of each drug, with comprehensive references to the primary literature, making this a mustโhave reference work for any academic or medical library, pharmacologist, regulatory organization, hospital dispensary, or pharmaceutical company.
The online version of the book provides an unparalleled depth of coverage and functionality by offering convenient desktop access and enhanced features such as increased searchability, extensive internal cross-linking, and fully downloadable and printable full-text, HTML or PDF articles.
- Enhanced encyclopedic format with drug monographs now organized alphabetically
- Completely expanded coverage of each drug, with more than 1,500 drug articles and information on adverse reactions and interactions
- Clearer, systematic organization of information for easier reading, including case histories to provide perspective on each listing
- Extensive bibliography with over 40,000 references
- A mustโhave reference work for any academic or medical library, pharmacologist, regulatory organization, hospital dispensary, or pharmaceutical company
เดฐเดเดฏเดฟเดคเดพเดตเดฟเดจเต เดเตเดฑเดฟเดเตเดเต
Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UKโs National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.
